This may be readily induced with intensive bronchodilator or steroid (cortisone, cortisol, prednisone or prednisolone) therapy, singly or in combination. This, we believe, is one of the essential ...

Physicians can use peak expiratory flow as a first-line tool for assessing variable airflow limitations among patients with ...

Mepolizumab added to triple therapy improves exacerbation outcomes in moderate to severe COPD and is effective to 2 years of ...

Nutritional therapy. This includes advice on what to ... COPD management includes short- and long-acting bronchodilators and other medicines that reduce inflammation in your lungs and help you ...

several authorities remain unconvinced that ICS are effective and recommend only LAMA + LABA combination bronchodilator therapy. Based on our experience, COPD patients with asthma or the ACOS may ...

AstraZeneca presented data from the phase 3 BATURA study which showed that use of Airsupra in those with mild asthma reduced ...

Bronchodilator therapy forms the mainstay of treatment for people with COPD. Bronchodilators work by altering the airways’ smooth muscle tone, leading to widening of the airways, which ...

Patients in the studies were also being treated with medium to high-dose inhaled corticosteroids (ICS), plus at least one additional bronchodilator therapy. Both studies met their primary ...

These bronchodilators work by relaxing tightened ... management recommend phosphodiesterase-4 inhibitors as an add-on therapy for people with persistent COPD symptoms and exacerbations despite ...

Nuance Pharma’s Ohtuvayre has met the primary endpoint in a Phase III chronic obstructive pulmonary disease (COPD) study in ...

The effects of equipotent doses of racemic albuterol and levalbuterol on heart rate (HR) in intensive care patients with and without baseline tachycardia were studied. Patients were included if ...

US-based biopharmaceutical company Connect Biopharma has started a Phase II trial to assess the efficacy and safety of ...